Nigerian agency issues warning on counterfeit malaria medications

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a warning to Nigerians about the circulation of counterfeit Combiart dispersible Tablet 20/120mg in Nigeria.

The medication, used to treat malaria, was discovered in the FCT and Rivers State as a counterfeit product during a surveillance operation by NAFDAC’s officers.

The counterfeit product, manufactured by Strides Arcolab Limited in India, was found to contain zero active pharmaceutical ingredients (APIs) and had two different date markings, NAFDAC confirmed.

NAFDAC’s database confirmed that the product’s license had expired, and the registration number on the product was incorrect.

According to the agency, “Counterfeit medicines endanger people’s health because they do not comply with regulatory standards, which means the safety, quality and efficacy of these products are not ensured.

“The use of counterfeit medicines often fails to effectively treat diseases or conditions, leading to serious health consequences, including death.”

NAFDAC has directed its zonal directors and state coordinators to conduct surveillance and remove the counterfeit products from circulation.

The agency has also advised importers, distributors, retailers, healthcare professionals, and caregivers to exercise caution when purchasing medical products to avoid the continuous importation, distribution, sale and use of counterfeit medical products.